Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
IBDV
iShares iBonds Dec 2030 Term Corporate ETF
|
-- | -- | -- | -- | -- |
|
IBDR
iShares iBonds Dec 2026 Term Corporate ETF
|
-- | -- | -- | -- | -- |
|
IBDS
iShares iBonds Dec 2027 Term Corporate ETF
|
-- | -- | -- | -- | -- |
|
IBDT
iShares iBonds Dec 2028 Term Corporate ETF
|
-- | -- | -- | -- | -- |
|
IBDU
iShares iBonds Dec 2029 Term Corporate ETF
|
-- | -- | -- | -- | -- |
|
IBDX
iShares iBonds Dec 2032 Term Corporate ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
IBDV
iShares iBonds Dec 2030 Term Corporate ETF
|
$22.12 | -- | -- | -- | $0.08 | 4.56% | -- |
|
IBDR
iShares iBonds Dec 2026 Term Corporate ETF
|
$24.23 | -- | -- | -- | $0.08 | 4.2% | -- |
|
IBDS
iShares iBonds Dec 2027 Term Corporate ETF
|
$24.31 | -- | -- | -- | $0.09 | 4.34% | -- |
|
IBDT
iShares iBonds Dec 2028 Term Corporate ETF
|
$25.49 | -- | -- | -- | $0.09 | 4.55% | -- |
|
IBDU
iShares iBonds Dec 2029 Term Corporate ETF
|
$23.45 | -- | -- | -- | $0.09 | 4.64% | -- |
|
IBDX
iShares iBonds Dec 2032 Term Corporate ETF
|
$25.59 | -- | -- | -- | $0.10 | 4.79% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
IBDV
iShares iBonds Dec 2030 Term Corporate ETF
|
-- | 0.548 | -- | -- |
|
IBDR
iShares iBonds Dec 2026 Term Corporate ETF
|
-- | 0.108 | -- | -- |
|
IBDS
iShares iBonds Dec 2027 Term Corporate ETF
|
-- | 0.180 | -- | -- |
|
IBDT
iShares iBonds Dec 2028 Term Corporate ETF
|
-- | 0.323 | -- | -- |
|
IBDU
iShares iBonds Dec 2029 Term Corporate ETF
|
-- | 0.379 | -- | -- |
|
IBDX
iShares iBonds Dec 2032 Term Corporate ETF
|
-- | 0.717 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
IBDV
iShares iBonds Dec 2030 Term Corporate ETF
|
-- | -- | -- | -- | -- | -- |
|
IBDR
iShares iBonds Dec 2026 Term Corporate ETF
|
-- | -- | -- | -- | -- | -- |
|
IBDS
iShares iBonds Dec 2027 Term Corporate ETF
|
-- | -- | -- | -- | -- | -- |
|
IBDT
iShares iBonds Dec 2028 Term Corporate ETF
|
-- | -- | -- | -- | -- | -- |
|
IBDU
iShares iBonds Dec 2029 Term Corporate ETF
|
-- | -- | -- | -- | -- | -- |
|
IBDX
iShares iBonds Dec 2032 Term Corporate ETF
|
-- | -- | -- | -- | -- | -- |
iShares iBonds Dec 2026 Term Corporate ETF has a net margin of -- compared to iShares iBonds Dec 2030 Term Corporate ETF's net margin of --. iShares iBonds Dec 2030 Term Corporate ETF's return on equity of -- beat iShares iBonds Dec 2026 Term Corporate ETF's return on equity of --.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
IBDV
iShares iBonds Dec 2030 Term Corporate ETF
|
-- | -- | -- |
|
IBDR
iShares iBonds Dec 2026 Term Corporate ETF
|
-- | -- | -- |
iShares iBonds Dec 2030 Term Corporate ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares iBonds Dec 2026 Term Corporate ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares iBonds Dec 2030 Term Corporate ETF has higher upside potential than iShares iBonds Dec 2026 Term Corporate ETF, analysts believe iShares iBonds Dec 2030 Term Corporate ETF is more attractive than iShares iBonds Dec 2026 Term Corporate ETF.
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
IBDV
iShares iBonds Dec 2030 Term Corporate ETF
|
0 | 0 | 0 |
|
IBDR
iShares iBonds Dec 2026 Term Corporate ETF
|
0 | 0 | 0 |
iShares iBonds Dec 2030 Term Corporate ETF has a beta of 1.166, which suggesting that the stock is 16.633% more volatile than S&P 500. In comparison iShares iBonds Dec 2026 Term Corporate ETF has a beta of 0.556, suggesting its less volatile than the S&P 500 by 44.443%.
iShares iBonds Dec 2030 Term Corporate ETF has a quarterly dividend of $0.08 per share corresponding to a yield of 4.56%. iShares iBonds Dec 2026 Term Corporate ETF offers a yield of 4.2% to investors and pays a quarterly dividend of $0.08 per share. iShares iBonds Dec 2030 Term Corporate ETF pays -- of its earnings as a dividend. iShares iBonds Dec 2026 Term Corporate ETF pays out -- of its earnings as a dividend.
iShares iBonds Dec 2030 Term Corporate ETF quarterly revenues are --, which are smaller than iShares iBonds Dec 2026 Term Corporate ETF quarterly revenues of --. iShares iBonds Dec 2030 Term Corporate ETF's net income of -- is lower than iShares iBonds Dec 2026 Term Corporate ETF's net income of --. Notably, iShares iBonds Dec 2030 Term Corporate ETF's price-to-earnings ratio is -- while iShares iBonds Dec 2026 Term Corporate ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares iBonds Dec 2030 Term Corporate ETF is -- versus -- for iShares iBonds Dec 2026 Term Corporate ETF. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
IBDV
iShares iBonds Dec 2030 Term Corporate ETF
|
-- | -- | -- | -- |
|
IBDR
iShares iBonds Dec 2026 Term Corporate ETF
|
-- | -- | -- | -- |
iShares iBonds Dec 2027 Term Corporate ETF has a net margin of -- compared to iShares iBonds Dec 2030 Term Corporate ETF's net margin of --. iShares iBonds Dec 2030 Term Corporate ETF's return on equity of -- beat iShares iBonds Dec 2027 Term Corporate ETF's return on equity of --.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
IBDV
iShares iBonds Dec 2030 Term Corporate ETF
|
-- | -- | -- |
|
IBDS
iShares iBonds Dec 2027 Term Corporate ETF
|
-- | -- | -- |
iShares iBonds Dec 2030 Term Corporate ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares iBonds Dec 2027 Term Corporate ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares iBonds Dec 2030 Term Corporate ETF has higher upside potential than iShares iBonds Dec 2027 Term Corporate ETF, analysts believe iShares iBonds Dec 2030 Term Corporate ETF is more attractive than iShares iBonds Dec 2027 Term Corporate ETF.
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
IBDV
iShares iBonds Dec 2030 Term Corporate ETF
|
0 | 0 | 0 |
|
IBDS
iShares iBonds Dec 2027 Term Corporate ETF
|
0 | 0 | 0 |
iShares iBonds Dec 2030 Term Corporate ETF has a beta of 1.166, which suggesting that the stock is 16.633% more volatile than S&P 500. In comparison iShares iBonds Dec 2027 Term Corporate ETF has a beta of 0.711, suggesting its less volatile than the S&P 500 by 28.909%.
iShares iBonds Dec 2030 Term Corporate ETF has a quarterly dividend of $0.08 per share corresponding to a yield of 4.56%. iShares iBonds Dec 2027 Term Corporate ETF offers a yield of 4.34% to investors and pays a quarterly dividend of $0.09 per share. iShares iBonds Dec 2030 Term Corporate ETF pays -- of its earnings as a dividend. iShares iBonds Dec 2027 Term Corporate ETF pays out -- of its earnings as a dividend.
iShares iBonds Dec 2030 Term Corporate ETF quarterly revenues are --, which are smaller than iShares iBonds Dec 2027 Term Corporate ETF quarterly revenues of --. iShares iBonds Dec 2030 Term Corporate ETF's net income of -- is lower than iShares iBonds Dec 2027 Term Corporate ETF's net income of --. Notably, iShares iBonds Dec 2030 Term Corporate ETF's price-to-earnings ratio is -- while iShares iBonds Dec 2027 Term Corporate ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares iBonds Dec 2030 Term Corporate ETF is -- versus -- for iShares iBonds Dec 2027 Term Corporate ETF. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
IBDV
iShares iBonds Dec 2030 Term Corporate ETF
|
-- | -- | -- | -- |
|
IBDS
iShares iBonds Dec 2027 Term Corporate ETF
|
-- | -- | -- | -- |
iShares iBonds Dec 2028 Term Corporate ETF has a net margin of -- compared to iShares iBonds Dec 2030 Term Corporate ETF's net margin of --. iShares iBonds Dec 2030 Term Corporate ETF's return on equity of -- beat iShares iBonds Dec 2028 Term Corporate ETF's return on equity of --.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
IBDV
iShares iBonds Dec 2030 Term Corporate ETF
|
-- | -- | -- |
|
IBDT
iShares iBonds Dec 2028 Term Corporate ETF
|
-- | -- | -- |
iShares iBonds Dec 2030 Term Corporate ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares iBonds Dec 2028 Term Corporate ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares iBonds Dec 2030 Term Corporate ETF has higher upside potential than iShares iBonds Dec 2028 Term Corporate ETF, analysts believe iShares iBonds Dec 2030 Term Corporate ETF is more attractive than iShares iBonds Dec 2028 Term Corporate ETF.
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
IBDV
iShares iBonds Dec 2030 Term Corporate ETF
|
0 | 0 | 0 |
|
IBDT
iShares iBonds Dec 2028 Term Corporate ETF
|
0 | 0 | 0 |
iShares iBonds Dec 2030 Term Corporate ETF has a beta of 1.166, which suggesting that the stock is 16.633% more volatile than S&P 500. In comparison iShares iBonds Dec 2028 Term Corporate ETF has a beta of 0.867, suggesting its less volatile than the S&P 500 by 13.253%.
iShares iBonds Dec 2030 Term Corporate ETF has a quarterly dividend of $0.08 per share corresponding to a yield of 4.56%. iShares iBonds Dec 2028 Term Corporate ETF offers a yield of 4.55% to investors and pays a quarterly dividend of $0.09 per share. iShares iBonds Dec 2030 Term Corporate ETF pays -- of its earnings as a dividend. iShares iBonds Dec 2028 Term Corporate ETF pays out -- of its earnings as a dividend.
iShares iBonds Dec 2030 Term Corporate ETF quarterly revenues are --, which are smaller than iShares iBonds Dec 2028 Term Corporate ETF quarterly revenues of --. iShares iBonds Dec 2030 Term Corporate ETF's net income of -- is lower than iShares iBonds Dec 2028 Term Corporate ETF's net income of --. Notably, iShares iBonds Dec 2030 Term Corporate ETF's price-to-earnings ratio is -- while iShares iBonds Dec 2028 Term Corporate ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares iBonds Dec 2030 Term Corporate ETF is -- versus -- for iShares iBonds Dec 2028 Term Corporate ETF. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
IBDV
iShares iBonds Dec 2030 Term Corporate ETF
|
-- | -- | -- | -- |
|
IBDT
iShares iBonds Dec 2028 Term Corporate ETF
|
-- | -- | -- | -- |
iShares iBonds Dec 2029 Term Corporate ETF has a net margin of -- compared to iShares iBonds Dec 2030 Term Corporate ETF's net margin of --. iShares iBonds Dec 2030 Term Corporate ETF's return on equity of -- beat iShares iBonds Dec 2029 Term Corporate ETF's return on equity of --.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
IBDV
iShares iBonds Dec 2030 Term Corporate ETF
|
-- | -- | -- |
|
IBDU
iShares iBonds Dec 2029 Term Corporate ETF
|
-- | -- | -- |
iShares iBonds Dec 2030 Term Corporate ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares iBonds Dec 2029 Term Corporate ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares iBonds Dec 2030 Term Corporate ETF has higher upside potential than iShares iBonds Dec 2029 Term Corporate ETF, analysts believe iShares iBonds Dec 2030 Term Corporate ETF is more attractive than iShares iBonds Dec 2029 Term Corporate ETF.
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
IBDV
iShares iBonds Dec 2030 Term Corporate ETF
|
0 | 0 | 0 |
|
IBDU
iShares iBonds Dec 2029 Term Corporate ETF
|
0 | 0 | 0 |
iShares iBonds Dec 2030 Term Corporate ETF has a beta of 1.166, which suggesting that the stock is 16.633% more volatile than S&P 500. In comparison iShares iBonds Dec 2029 Term Corporate ETF has a beta of 1.007, suggesting its more volatile than the S&P 500 by 0.72700000000001%.
iShares iBonds Dec 2030 Term Corporate ETF has a quarterly dividend of $0.08 per share corresponding to a yield of 4.56%. iShares iBonds Dec 2029 Term Corporate ETF offers a yield of 4.64% to investors and pays a quarterly dividend of $0.09 per share. iShares iBonds Dec 2030 Term Corporate ETF pays -- of its earnings as a dividend. iShares iBonds Dec 2029 Term Corporate ETF pays out -- of its earnings as a dividend.
iShares iBonds Dec 2030 Term Corporate ETF quarterly revenues are --, which are smaller than iShares iBonds Dec 2029 Term Corporate ETF quarterly revenues of --. iShares iBonds Dec 2030 Term Corporate ETF's net income of -- is lower than iShares iBonds Dec 2029 Term Corporate ETF's net income of --. Notably, iShares iBonds Dec 2030 Term Corporate ETF's price-to-earnings ratio is -- while iShares iBonds Dec 2029 Term Corporate ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares iBonds Dec 2030 Term Corporate ETF is -- versus -- for iShares iBonds Dec 2029 Term Corporate ETF. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
IBDV
iShares iBonds Dec 2030 Term Corporate ETF
|
-- | -- | -- | -- |
|
IBDU
iShares iBonds Dec 2029 Term Corporate ETF
|
-- | -- | -- | -- |
iShares iBonds Dec 2032 Term Corporate ETF has a net margin of -- compared to iShares iBonds Dec 2030 Term Corporate ETF's net margin of --. iShares iBonds Dec 2030 Term Corporate ETF's return on equity of -- beat iShares iBonds Dec 2032 Term Corporate ETF's return on equity of --.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
IBDV
iShares iBonds Dec 2030 Term Corporate ETF
|
-- | -- | -- |
|
IBDX
iShares iBonds Dec 2032 Term Corporate ETF
|
-- | -- | -- |
iShares iBonds Dec 2030 Term Corporate ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares iBonds Dec 2032 Term Corporate ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares iBonds Dec 2030 Term Corporate ETF has higher upside potential than iShares iBonds Dec 2032 Term Corporate ETF, analysts believe iShares iBonds Dec 2030 Term Corporate ETF is more attractive than iShares iBonds Dec 2032 Term Corporate ETF.
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
IBDV
iShares iBonds Dec 2030 Term Corporate ETF
|
0 | 0 | 0 |
|
IBDX
iShares iBonds Dec 2032 Term Corporate ETF
|
0 | 0 | 0 |
iShares iBonds Dec 2030 Term Corporate ETF has a beta of 1.166, which suggesting that the stock is 16.633% more volatile than S&P 500. In comparison iShares iBonds Dec 2032 Term Corporate ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
iShares iBonds Dec 2030 Term Corporate ETF has a quarterly dividend of $0.08 per share corresponding to a yield of 4.56%. iShares iBonds Dec 2032 Term Corporate ETF offers a yield of 4.79% to investors and pays a quarterly dividend of $0.10 per share. iShares iBonds Dec 2030 Term Corporate ETF pays -- of its earnings as a dividend. iShares iBonds Dec 2032 Term Corporate ETF pays out -- of its earnings as a dividend.
iShares iBonds Dec 2030 Term Corporate ETF quarterly revenues are --, which are smaller than iShares iBonds Dec 2032 Term Corporate ETF quarterly revenues of --. iShares iBonds Dec 2030 Term Corporate ETF's net income of -- is lower than iShares iBonds Dec 2032 Term Corporate ETF's net income of --. Notably, iShares iBonds Dec 2030 Term Corporate ETF's price-to-earnings ratio is -- while iShares iBonds Dec 2032 Term Corporate ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares iBonds Dec 2030 Term Corporate ETF is -- versus -- for iShares iBonds Dec 2032 Term Corporate ETF. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
IBDV
iShares iBonds Dec 2030 Term Corporate ETF
|
-- | -- | -- | -- |
|
IBDX
iShares iBonds Dec 2032 Term Corporate ETF
|
-- | -- | -- | -- |
Signup to receive the latest stock alerts
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Though certainly less well-known than the huge tech businesses that…
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Market Cap: $4.6T
P/E Ratio: 65x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 29x
Teradata Corp. [TDC] is down 11.64% over the past day.
Diodes, Inc. [DIOD] is down 7.63% over the past day.
Vertiv Holdings Co. [VRT] is down 4.79% over the past day.